|
|
Volumn 42, Issue 1, 2011, Pages 6-11
|
|
Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration
a
a,b
b
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
ADULT;
AGED;
ARTICLE;
BIOMICROSCOPY;
CLINICAL ARTICLE;
DISEASE COURSE;
EPIRETINAL MEMBRANE;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
IMAGE ANALYSIS;
MALE;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RETINA HEMORRHAGE;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA NEOVASCULARIZATION;
RETROSPECTIVE STUDY;
SUBRETINA FIBROSIS;
SUBRETINAL FIBROSIS;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
DRUG EFFECT;
FIBROSIS;
INTRAVITREAL DRUG ADMINISTRATION;
MIDDLE AGED;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RETINA;
RETINA MACULA DEGENERATION;
SUBRETINAL NEOVASCULARIZATION;
VISUAL DISORDER;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
DISEASE PROGRESSION;
FEMALE;
FIBROSIS;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INTRAVITREAL INJECTIONS;
MACULAR DEGENERATION;
MALE;
MIDDLE AGED;
RETINA;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISION DISORDERS;
VISUAL ACUITY;
|
|
EID: 79954441959
PISSN: 15428877
EISSN: None
Source Type: Journal
DOI: 10.3928/15428877-20100924-01 Document Type: Article |
|
Times cited : (65)
|
|
References (9)
|
